Life after rare ovarian cancer: the hidden costs of survival
NCT ID NCT03418844
Summary
This study aims to understand the long-term challenges faced by women who have survived rare ovarian cancers. Researchers are comparing 268 women who received chemotherapy plus surgery to those who had surgery alone, focusing on chronic fatigue, quality of life, and late effects of treatment. The goal is to gather knowledge about how cancer and its treatments affect survivors' lives years after remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Fleyriat
Bourg-en-Bresse, France
-
CHRU Stasbourg Hôpital Civil
Strasbourg, France
-
CHU Besançon Jean MINJOZ
Besançon, France
-
CHU Poitiers
Poitiers, France
-
Centre Catherine de Sienne
Nantes, France
-
Centre François Baclesse
Caen, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Léon Berard
Lyon, France
-
Centre Paul Papin
Angers, France
-
GH Cochin Broca Hôtel-Dieu
Paris, France
-
HEGP
Paris, Paris, France
-
Hôpital Diaconesses-Croix St Simon
Paris, France
-
Institut Bergonié
Bordeaux, France
-
Institut Curie,
Paris, France
-
Institut Gustave Roussy
Paris, France
-
Institut Jean Godinot
Reims, France
-
Institut Paoli Calmettes
Marseille, France
-
Institut Rennais de Cancérologie
Rennes, France
-
Institut de Cancérologie de l'Ouest
Nantes, France
Conditions
Explore the condition pages connected to this study.